language Türkçe
Article Early Access 2026 · 0 citations

Synthesis, characterization, and lipoxygenase inhibition of salicylaldehyde-derived schiff base metal complexes: enzymatic and in silico evaluation using quinoa lipoxygenase

Ereminsoy, Ergun, Demir, Yeliz, Yildirim, Sumeyra Tuna, Turkes, Cuneyt, Kufrevioglu, Omer Irfan

Abstract

In the present study, novel Schiff base ligands were synthesized via the condensation of salicylaldehyde derivatives with o-aminophenol, and their metal complexes with Co(II), Ni(II), Cu(II), Zn(II), Cd(II), and UO2(VI) metal actetates were successfully prepared. The compounds were comprehensively characterized using FT-IR, H-1-NMR, C-13-NMR, UV-Vis spectroscopy, X-ray diffraction (XRD), scanning electron microscopy (SEM), and magnetic susceptibility measurements. FT-IR spectra confirmed azomethine (C = N) coordination through characteristic bands at 1612-1630 cm(-1), while H-1-NMR spectra exhibited diagnostic azomethine proton signals at delta 8.84-8.62 ppm. XRD analysis revealed a semi-crystalline nature with prominent reflections at 2 theta = 18.02 degrees and 20.87 degrees, and SEM images demonstrated nanorod-like morphologies. Magnetic moment values supported the proposed coordination geometries of the paramagnetic complexes. The biological activity of the synthesized compounds was investigated through in vitro inhibition studies against lipoxygenase (LOX), a similar to 97 kDa enzyme purified from Chenopodium quinoa Willd. with 77.89% purity and 7.24% yield. All compounds exhibited competitive inhibition toward LOX, with inhibition constants (K-i) in the range of 0.014 +/- 0.002 to 0.858 +/- 0.194 mu M, indicating remarkable inhibitory potency. Molecular docking studies further substantiated the experimental results by revealing key hydrogen-bonding and pi-cation interactions between the most active compounds and essential amino acid residues within the LOX active site. Overall, the results demonstrate that these Schiff base metal complexes represent promising candidates for the development of potent LOX inhibitors.

Keywords
Metal complexes Characterization Lipoxygenase Molecular docking Schiff base PURIFICATION MONONUCLEAR ANTITUMOR DOCKING PROTEIN ACID
WoS Categories
Pharmacology & Pharmacy
Sustainable Development Goals
Citation
Journal
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Year
2026
ISSN
0028-1298
eISSN
1432-1912
DOI
10.1007/s00210-025-04955-6
WoS UID
WOS:001663166300001
Open via DOI